Sepsis in humans may indeed be by characterized either by fever or hypothermia (80) and in rats injected with high doses of LPS hypothermia may be observed either shortly after LPS challenge (81) or at the later phase of experimental sickness syndrome (10). The latter report gives evidence for a continuum of changes in body temperature starting with a hypermetabolic state with fever and pain under any thermal conditions which is than followed by a gradual reversal into a more passive, hypometabolic state, the latter allowing hypo- or hyperthermia depending on the thermal conditions of the environment. In other words, this later phase of „fever” may be characterized by a broad-band control of thermoregulation (82) with other components of sickness behavior (inactivity, anorexia, sleepiness, etc.) remaining largely the same.
A more or less marked lability of thermoregulation may be accounted for by an inability to increased heat production on cold exposure, widening of the so-called interthreshold zone of regulation (i. e. between core temperature threshold for increased heat loss and that for shivering). Interpretation of a fall in body temperature during severe illness ranges from an inability of central or peripheral thermoregulatory mechanisms to insure homeothermy, on the one hand, to a coordinated set of physiological changes leading to a lower set-point, hence to a „central” or regulated hypothermia. The latter interpretation envisages some purpose or biological logic that may serve survival of the sick individual. This opinion has been supported by the finding that rodents made hypothermic by hypoxia or various toxins may prefer lower ambient temperatures when the choice is given to them to seek an optimal thermal environment (83, 84, 85). As for the likely mechanism of hypothermia in animals injected with LPS the only study published so far indicates also a parallel change of selected ambient temperature and core temperature (81). Possible relationship between LPS- induced hypothermia and sickness behavior has not been studied in detail with one exception. In particular, body temperature, activity, food- and water-intake were followed in rats after an i.p. injection of high dose of LPS (86). A pretreatment with a TNF-binding protein led to an enhancement of LPS-fever, while the decrease in food- and water-intake was abolished. Interestingly, the initial hypothermia - indicating a shock-like state - and the fall in general activity remained unchanged after the inhibition of TNF-effect. These data support the notion that TNF may be regarded as a cryogenic mediator and demonstrate that various components of sickness behavior and the two phases of body temperature change (hyper- or hypothermia) may have partly different mediation, the nature of which are far from being clear.
Central or regulated hypothermia – sometimes called also anapyrexia when the phenomenon is supposed to act as an antipyretic mechanism – was observed under conditions which may also be present during disease states. Among others, hypoxia could be a pathophysiological state that may also accompany some diseases affecting circulation, respiration or metabolism. In fact, hypoxia induces hypothermia together with a decreased motor activity in rats and may disturb circadian changes of these two parameters differently (87). As for the mechanism of hypoxic hypothermia several mediators have been suggested such as nitric oxide (88) but not vasopressin (89), lactate known to be connected to tissue hypoxia acting as a metabolic inhibitor doses apparently not mediating this anapyrexic response, either (90). Another factor likely contributing to metabolic derangements in various disease states is hypoglycemia (91). According to recent studies the hem-oxigenase product, carbon monoxide may have a role in hypothermia of hypoglycemia induced by insulin in rats (92). The lack of information on changes in other aspects of sickness behavior does not allow any conclusions to be made on possible causal relationship between regulated hypothermia and symptoms of diseases affecting energy regulation.